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EDITORIAL COMMENTARYIs a 1% isolated coronary artery bypass grafting mortality
really a valid goal?Richard Lee, MD, MBASee related article on pages 2686-96.‘‘The Challenge of Achieving 1% Operative Mortality for
Coronary Artery Bypass Grafting: AMulti-institution Soci-
ety of Thoracic Surgeons Database Analysis,’’ by LaPar and
colleagues in this issue of the Journal, is a sophisticated
analysis that uses hierarchic multiple regression models in
a population of 34,416 patients undergoing isolated primary
coronary artery bypass grafting (CABG) at the 17 Virginia
Cardiac Surgery Quality Initiative institutions during an
11-year period. In the article, LaPar and colleagues explore
the feasibility of obtaining 1% mortality for patients in this
population.
In short, they conclude that achieving 1%mortality is not
likely in the entire population. By means of the Society of
Thoracic Surgeons Predicted Risk of Mortality (PROM),
they have determined that a mortality of less than 1% can
be achieved when the PROM is at or below 1.27%. This
includes 57% of the population.
This article is an important start to inevitable discussions
in our challenging and evolving health care environment.
As a cardiothoracic community, we have led the field of
medicine in measures of outcome and used them for quality
improvement. As such, we are, at times, victims of our own
success. The use of our data for publically available
reporting allows patients to choose a surgeon and institution
that offers the best outcome. I hope that we all believe that
this is a public service. As this article suggests, however,
even with adjusted risk, at times the data are unreliable.
In particular, the PROM scores were inaccurate above
25%. Moreover, in the high-risk patients, when PROM
was 4.6% or above, the decedents had striking differences
in risk profiles that included preoperative dialysis, heart
failure, and emergency surgery. LaPar and colleagues go
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penalized for disproportionally high mortalities.
With indiscriminate public emphasis on mortality, even
risk adjusted, the inevitable surgical response will be to
move toward zero mortality. If the target arbitrarily is
placed at 1% mortality, this may lead to rationing of care
in the high-risk patient population. LaPar and colleagues
suggest that a 1% mortality goal in only reasonable for
approximately 60% of patients, leaving potentially 40%
of patients at risk for restriction of care. Clearly, this bar
is too high.
There are several limitations in the article that highlight
challenges with quality reporting. This study does not
address morbidity. Although there may be a correlation,
at times there may be a trade-off. There are some devas-
tating complications of cardiac surgery that some patients
would find equivalent to mortality. In addition, surgical
volume was initially only measured by isolated CABG
procedures. Subsequent analysis confirmed that it was
correlated with total cardiac volume. This is, however, a
potential pitfall in public reporting. For example, a surgeon
who performs only 1 isolated CABG procedure per week
but 4 combined CABG and valve procedures should likely
be comparable to a surgeon who performs 5 CABG proce-
dures per week. In that vein, total surgeon experience was
not available. The number of lifetime operations is also an
important consideration. Lastly, fewer deceased patients
received discharge medicines, and this was discussed as
a process improvement opportunity. This again highlights
a pitfall of traditional reporting and indiscriminate
emphasis on secondary end points, such as administration
of specific medicines before discharge. Likely, the medi-
cines were inappropriate in many of these cases. For
example, it makes no sense to start a b-blocker for some-
one already receiving a b-agonist. A patient receiving ino-
tropes after surgery is less likely to be a survivor. The same
is true for an antihypertensive agent in a patient with low
blood pressure. A completely low-risk, healthy patient
with a good operation is likely to receive all of his or
her medication. A patient who is bleeding or one with
low platelets from heparin-induced thrombocytopenia is
unlikely to receive aspirin. Even our sophisticated database
is unlikely to be able to determine whether the medication
is the cause or the effect of an untoward event in some
patients. Overemphasis on specific medications inappro-
priately misplaces our focus off target.
Accurate measures of quality are extremely complex. Pub-
lic reporting systems such as LeapFrog and HealthGradesdiovascular Surgery c Volume 148, Number 6 2697
Editorial Commentary Leetend to attempt to distill the metric to something that a
layperson can understand, such as a ‘‘grade’’ or a ‘‘mortality
number.’’ We know that this type of metric can be deceptive
and inaccurate. As thoracic surgeons, we have developed a
culture of innovation, not only in the treatment of patients
but also in the areas of measuring and reporting outcomes.
Our next frontier should focus on developing a reporting
system that is more accurate and encompassing. We should
work with the existing popular reports and help with
modifications. In addition, we should help educate the public2698 The Journal of Thoracic and Cardiovascular Suras to the strengths andweaknesses of the reporting system.As
a community, our goal has always been to improve quality.
This article highlights the fact that we need to be more active
participants in describing quality in a manner that does not
lead to restriction of reasonable care. Moreover, we should
be thoughtful and use the data to set new goals, rather than
arbitrarily setting goals only to find out that they cannot be
achieved. Reports like these demonstrate that we are in the
‘‘pole position’’ in data-driven quality reforms. We have yet
another opportunity to stay in the lead.gery c December 2014
